The global Intelligent Cancer Care (ICC) market was valued at US$ 916.8 million in 2022 and is projected to reach US$ 4876.8 million by 2029, at a CAGR of 27.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cancer Prevention and Screening Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intelligent Cancer Care (ICC) include Varian (Siemens), CityCancerChallenge, Canon, VieCure, Sophia Genetics, Freenome, Pfizer, IBM and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Intelligent Cancer Care (ICC) is kind of information-driven network of next generation oncology solutions that bring people, data, and technology together to manage a more intelligent approach to cancer care.
This report aims to provide a comprehensive presentation of the global market for Intelligent Cancer Care (ICC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intelligent Cancer Care (ICC). This report contains market size and forecasts of Intelligent Cancer Care (ICC) in global, including the following market information:
Global Intelligent Cancer Care (ICC) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intelligent Cancer Care (ICC) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intelligent Cancer Care (ICC) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Intelligent Cancer Care (ICC) Market Segment Percentages, by Type, 2022 (%)
Cancer Prevention and Screening
AI-Assisted Diagnosis
Prediction of Treatment Outcome
Intelligent Radiation Oncology
Tele-Oncology
Global Intelligent Cancer Care (ICC) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Intelligent Cancer Care (ICC) Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
Global Intelligent Cancer Care (ICC) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Intelligent Cancer Care (ICC) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intelligent Cancer Care (ICC) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Intelligent Cancer Care (ICC) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Varian (Siemens)
CityCancerChallenge
Canon
VieCure
Sophia Genetics
Freenome
Pfizer
IBM
Sanofi
GSK
Roche
Exscientia
BenevolentAI
Bayer
Philips
GE Healthcare
Azra AI
Path AI
NVIDIA
ConcertAI
Digital Diagnostics
Median Technologies
BioNTech SE
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intelligent Cancer Care (ICC), market overview.
Chapter 2: Global Intelligent Cancer Care (ICC) market size in revenue.
Chapter 3: Detailed analysis of Intelligent Cancer Care (ICC) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intelligent Cancer Care (ICC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Intelligent Cancer Care (ICC) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intelligent Cancer Care (ICC) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intelligent Cancer Care (ICC) Overall Market Size
2.1 Global Intelligent Cancer Care (ICC) Market Size: 2022 VS 2029
2.2 Global Intelligent Cancer Care (ICC) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Intelligent Cancer Care (ICC) Players in Global Market
3.2 Top Global Intelligent Cancer Care (ICC) Companies Ranked by Revenue
3.3 Global Intelligent Cancer Care (ICC) Revenue by Companies
3.4 Top 3 and Top 5 Intelligent Cancer Care (ICC) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Intelligent Cancer Care (ICC) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intelligent Cancer Care (ICC) Players in Global Market
3.6.1 List of Global Tier 1 Intelligent Cancer Care (ICC) Companies
3.6.2 List of Global Tier 2 and Tier 3 Intelligent Cancer Care (ICC) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Intelligent Cancer Care (ICC) Market Size Markets, 2022 & 2029
4.1.2 Cancer Prevention and Screening
4.1.3 AI-Assisted Diagnosis
4.1.4 Prediction of Treatment Outcome
4.1.5 Intelligent Radiation Oncology
4.1.6 Tele-Oncology
4.2 By Type - Global Intelligent Cancer Care (ICC) Revenue & Forecasts
4.2.1 By Type - Global Intelligent Cancer Care (ICC) Revenue, 2018-2023
4.2.2 By Type - Global Intelligent Cancer Care (ICC) Revenue, 2024-2029
4.2.3 By Type - Global Intelligent Cancer Care (ICC) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Intelligent Cancer Care (ICC) Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Lung Cancer
5.1.4 Prostate Cancer
5.1.5 Colorectal Cancer
5.1.6 Brain Tumor
5.1.7 Others
5.2 By Application - Global Intelligent Cancer Care (ICC) Revenue & Forecasts
5.2.1 By Application - Global Intelligent Cancer Care (ICC) Revenue, 2018-2023
5.2.2 By Application - Global Intelligent Cancer Care (ICC) Revenue, 2024-2029
5.2.3 By Application - Global Intelligent Cancer Care (ICC) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Intelligent Cancer Care (ICC) Market Size, 2022 & 2029
6.2 By Region - Global Intelligent Cancer Care (ICC) Revenue & Forecasts
6.2.1 By Region - Global Intelligent Cancer Care (ICC) Revenue, 2018-2023
6.2.2 By Region - Global Intelligent Cancer Care (ICC) Revenue, 2024-2029
6.2.3 By Region - Global Intelligent Cancer Care (ICC) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Intelligent Cancer Care (ICC) Revenue, 2018-2029
6.3.2 US Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.3.3 Canada Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.3.4 Mexico Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Intelligent Cancer Care (ICC) Revenue, 2018-2029
6.4.2 Germany Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.4.3 France Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.4.4 U.K. Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.4.5 Italy Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.4.6 Russia Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.4.7 Nordic Countries Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.4.8 Benelux Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Intelligent Cancer Care (ICC) Revenue, 2018-2029
6.5.2 China Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.5.3 Japan Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.5.4 South Korea Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.5.5 Southeast Asia Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.5.6 India Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Intelligent Cancer Care (ICC) Revenue, 2018-2029
6.6.2 Brazil Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.6.3 Argentina Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Intelligent Cancer Care (ICC) Revenue, 2018-2029
6.7.2 Turkey Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.7.3 Israel Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.7.4 Saudi Arabia Intelligent Cancer Care (ICC) Market Size, 2018-2029
6.7.5 UAE Intelligent Cancer Care (ICC) Market Size, 2018-2029
7 Intelligent Cancer Care (ICC) Companies Profiles
7.1 Varian (Siemens)
7.1.1 Varian (Siemens) Company Summary
7.1.2 Varian (Siemens) Business Overview
7.1.3 Varian (Siemens) Intelligent Cancer Care (ICC) Major Product Offerings
7.1.4 Varian (Siemens) Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.1.5 Varian (Siemens) Key News & Latest Developments
7.2 CityCancerChallenge
7.2.1 CityCancerChallenge Company Summary
7.2.2 CityCancerChallenge Business Overview
7.2.3 CityCancerChallenge Intelligent Cancer Care (ICC) Major Product Offerings
7.2.4 CityCancerChallenge Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.2.5 CityCancerChallenge Key News & Latest Developments
7.3 Canon
7.3.1 Canon Company Summary
7.3.2 Canon Business Overview
7.3.3 Canon Intelligent Cancer Care (ICC) Major Product Offerings
7.3.4 Canon Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.3.5 Canon Key News & Latest Developments
7.4 VieCure
7.4.1 VieCure Company Summary
7.4.2 VieCure Business Overview
7.4.3 VieCure Intelligent Cancer Care (ICC) Major Product Offerings
7.4.4 VieCure Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.4.5 VieCure Key News & Latest Developments
7.5 Sophia Genetics
7.5.1 Sophia Genetics Company Summary
7.5.2 Sophia Genetics Business Overview
7.5.3 Sophia Genetics Intelligent Cancer Care (ICC) Major Product Offerings
7.5.4 Sophia Genetics Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.5.5 Sophia Genetics Key News & Latest Developments
7.6 Freenome
7.6.1 Freenome Company Summary
7.6.2 Freenome Business Overview
7.6.3 Freenome Intelligent Cancer Care (ICC) Major Product Offerings
7.6.4 Freenome Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.6.5 Freenome Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Intelligent Cancer Care (ICC) Major Product Offerings
7.7.4 Pfizer Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 IBM
7.8.1 IBM Company Summary
7.8.2 IBM Business Overview
7.8.3 IBM Intelligent Cancer Care (ICC) Major Product Offerings
7.8.4 IBM Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.8.5 IBM Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Intelligent Cancer Care (ICC) Major Product Offerings
7.9.4 Sanofi Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Intelligent Cancer Care (ICC) Major Product Offerings
7.10.4 GSK Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 Roche
7.11.1 Roche Company Summary
7.11.2 Roche Business Overview
7.11.3 Roche Intelligent Cancer Care (ICC) Major Product Offerings
7.11.4 Roche Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.11.5 Roche Key News & Latest Developments
7.12 Exscientia
7.12.1 Exscientia Company Summary
7.12.2 Exscientia Business Overview
7.12.3 Exscientia Intelligent Cancer Care (ICC) Major Product Offerings
7.12.4 Exscientia Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.12.5 Exscientia Key News & Latest Developments
7.13 BenevolentAI
7.13.1 BenevolentAI Company Summary
7.13.2 BenevolentAI Business Overview
7.13.3 BenevolentAI Intelligent Cancer Care (ICC) Major Product Offerings
7.13.4 BenevolentAI Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.13.5 BenevolentAI Key News & Latest Developments
7.14 Bayer
7.14.1 Bayer Company Summary
7.14.2 Bayer Business Overview
7.14.3 Bayer Intelligent Cancer Care (ICC) Major Product Offerings
7.14.4 Bayer Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.14.5 Bayer Key News & Latest Developments
7.15 Philips
7.15.1 Philips Company Summary
7.15.2 Philips Business Overview
7.15.3 Philips Intelligent Cancer Care (ICC) Major Product Offerings
7.15.4 Philips Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.15.5 Philips Key News & Latest Developments
7.16 GE Healthcare
7.16.1 GE Healthcare Company Summary
7.16.2 GE Healthcare Business Overview
7.16.3 GE Healthcare Intelligent Cancer Care (ICC) Major Product Offerings
7.16.4 GE Healthcare Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.16.5 GE Healthcare Key News & Latest Developments
7.17 Azra AI
7.17.1 Azra AI Company Summary
7.17.2 Azra AI Business Overview
7.17.3 Azra AI Intelligent Cancer Care (ICC) Major Product Offerings
7.17.4 Azra AI Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.17.5 Azra AI Key News & Latest Developments
7.18 Path AI
7.18.1 Path AI Company Summary
7.18.2 Path AI Business Overview
7.18.3 Path AI Intelligent Cancer Care (ICC) Major Product Offerings
7.18.4 Path AI Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.18.5 Path AI Key News & Latest Developments
7.19 NVIDIA
7.19.1 NVIDIA Company Summary
7.19.2 NVIDIA Business Overview
7.19.3 NVIDIA Intelligent Cancer Care (ICC) Major Product Offerings
7.19.4 NVIDIA Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.19.5 NVIDIA Key News & Latest Developments
7.20 ConcertAI
7.20.1 ConcertAI Company Summary
7.20.2 ConcertAI Business Overview
7.20.3 ConcertAI Intelligent Cancer Care (ICC) Major Product Offerings
7.20.4 ConcertAI Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.20.5 ConcertAI Key News & Latest Developments
7.21 Digital Diagnostics
7.21.1 Digital Diagnostics Company Summary
7.21.2 Digital Diagnostics Business Overview
7.21.3 Digital Diagnostics Intelligent Cancer Care (ICC) Major Product Offerings
7.21.4 Digital Diagnostics Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.21.5 Digital Diagnostics Key News & Latest Developments
7.22 Median Technologies
7.22.1 Median Technologies Company Summary
7.22.2 Median Technologies Business Overview
7.22.3 Median Technologies Intelligent Cancer Care (ICC) Major Product Offerings
7.22.4 Median Technologies Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.22.5 Median Technologies Key News & Latest Developments
7.23 BioNTech SE
7.23.1 BioNTech SE Company Summary
7.23.2 BioNTech SE Business Overview
7.23.3 BioNTech SE Intelligent Cancer Care (ICC) Major Product Offerings
7.23.4 BioNTech SE Intelligent Cancer Care (ICC) Revenue in Global Market (2018-2023)
7.23.5 BioNTech SE Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report